Synchrotron supported DEI/KES of a brain tumor in an animal model: The search for a microimaging modality

✍ Scribed by K.A. Mannan; E. Schültke; R.H. Menk; K. Siu; K. Pavlov; M. Kelly; G. McLoughlin; T. Beveridge; G. Tromba; B.H. Juurlink; D. Chapman; L. Rigon; R.W. Griebel

• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 519 KB
• Volume: 548
• Category: Article
• ISSN: 0168-9002
• DOI: 10.1016/j.nima.2005.03.075

✦ Synopsis

Glioblastoma multiforme (GBM) is the commonest and most aggressive primary brain tumor in humans. The high rate of tumor recurrence results in a poor prognosis despite multimodality treatment. One reason for high rate of recurrence is the invasive nature of the tumor into the surrounding normal brain tissue or multifocal occurrence at sites remote from that of the primary tumor establishment. Existing imaging demonstrates the primary tumor but fail to show the residual tumor microaggregates left behind following initial treatment. In this study, we employed diffractionenhanced imaging (DEI) in an attempt to find an imaging modality that will provide visualization of residual disease that is not be apparent on MRI or CT scans.